Abnormalities in renal dopamine signaling and hypertension: The role of GRK4

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 1, 2012, Pages 61-65

  Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin; dopamine; G protein receptor kinases; hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR; DOPAMINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 4; OPSIN;

BINDING SITE; BLOOD PRESSURE REGULATION; DESENSITIZATION; DIURESIS; DOPAMINERGIC SYSTEM; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY TUBULE ABSORPTION; LIGAND BINDING; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM EXCRETION; SODIUM URINE LEVEL; UBIQUITINATION;

ANIMALS; BLOOD PRESSURE; DOPAMINE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY;

EID: 83055164437     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834de2cb     Document Type: Review

References (57)

1. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2:637-650. (Pubitemid 44655641)
2. Bacic D, Capuano P, Baum M, et al. Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 2005; 288:F740-F747. (Pubitemid 40381741)
3. Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol 2003; 473:185-190. (Pubitemid 36929883)
4. Wang X, Luo Y, Escano CS, Yang Z, et al. Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension 2010; 55:1431-1437.
5. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62:621-647. (Pubitemid 30618277)
6. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension 2011; 57:11-17.
7. Asico L, Zhang X, Jiang J, et al. Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol 2011; 22:82-89.
8. Quinones H, Collazo R, Moe OW. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol 2004; 287:F74-F80. (Pubitemid 38780585)
9. Pinho MJ, Serrao MP, Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2007; 292:F1452-F1463. (Pubitemid 46701873)
10. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990; 258:F28-F33. (Pubitemid 20063065)
11. Bertorello A, Hokfelt T, Goldstein M, Aperia A. Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol 1988; 254:F795-F801.
12. Baines AD. Effects of salt intake and renal denervation on catecholamine catabolism and excretion. Kidney Int 1982; 21:316-322. (Pubitemid 12136666)
13. Chen CJ, Apparsundaram S, Lokhandwala MF. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 1991; 256:486-491.
14. Gesek FA, Schoolwerth AC. Hormone responses of proximal Na(+)-H+ exchanger in spontaneously hypertensive rats. Am J Physiol 1991; 261:F526-F536.
15. Zhang MZ, Yao B, Fang X, et al. Intrarenal dopaminergic system regulates renin expression. Hypertension 2009; 53:564-570.
16. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 1996; 97:2745-2752. (Pubitemid 26197089)
17. Aperia A, Holtback U, Syren ML, et al. Activation/deactivation of renal Na+,K(+)-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994; 8:436-439. (Pubitemid 24155957)
18. Zeng C, Liu Y, Wang Z, et al. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 2006; 99:494-500. (Pubitemid 44337821)
19. Zeng C, Yang Z, Wang Z, et al. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 2005; 45:804-810. (Pubitemid 40418385)
20. Zeng C, Sanada H, Watanabe H, et al. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-246.
21. Sidhu A, Kumar U, Uh M, Patel S. Diminished expression of renal dopamine D1A receptors in the kidney inner medulla of the spontaneously hypertensive rat. J Hypertens 1998; 16:601-608. (Pubitemid 28230548)
22. Iimura O. The role of renal dopaminergic activity in the pathophysiology of essential hypertension. Jpn Heart J 1996; 37:815-828. (Pubitemid 27029378)
23. Shikuma R, Yoshimura M, Kambara S, et al. Dopaminergic modulation of salt sensitivity in patients with essential hypertension. Life Sci 1986; 38:915-921. (Pubitemid 16107548)
24. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G proteincoupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802:1259-1267.
25. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121:2845-2854.
26. Premont RT, Macrae AD, Aparicio SA, et al. The GRK4 subfamily ofGproteincoupled receptor kinases. Alternative splicing, gene organization, and sequence conservation. J Biol Chem 1999; 274:29381-29389.
27. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99:3872-3877. (Pubitemid 34252198)
28. Nishi A, Eklof AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na+,K(+)-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993; 21:767-771. (Pubitemid 23171638)
29. Hussain T, Lokhandwala MF. Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am J Physiol 1997; 272:F339-F346.
30. Debska-Slizien A, Ho P, Drangova R, Baines AD. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994; 5:1125-1132. (Pubitemid 24977091)
31. Sanada H, Jose PA, Hazen-Martin D, et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33:1036-1042. (Pubitemid 29186405)
32. Gildea JJ, Shah I, Weiss R, et al. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension 2010; 56:505-511.
33. Villar VA, Jones JE, Armando I, et al. G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem 2009; 284:21425-21434.
34. Jose PA, Soares-d-Silav P, Eisner GM, Felder RA. Dopamine and G proteincoupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802:1259-1267.
35. Allayee H, de Bruin TW, Michelle Dominguez K, et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38:773-778. (Pubitemid 34258669)
36. Chen W, Li S, Srinivasan SR, et al. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood: the Bogalusa Heart Study. Hypertension 2005; 45:954-959. (Pubitemid 40628943)
37. Lohmueller KE, Wong LJ, Mauney MM, et al. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet 2006; 70:27-41. (Pubitemid 43355559)
38. Bengra C, Mifflin TE, Khripin Y, et al. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 2002; 48:2131-2140. (Pubitemid 35397554)
39. Speirs HJ, Katyk K, Kumar NN, et al. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22:931-936. (Pubitemid 38680467)
40. Wang Y, Li B, Zhao W, et al. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese. Ann Hum Genet 2006; 70:778-783. (Pubitemid 44530641)
41. Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52:352-360.
42. Williams SM, Ritchie MD, Phillips JA, 3rd, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004; 57:28-38. (Pubitemid 38608307)
43. Bhatnagar V, O'Connor DT, Brophy VH, et al. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens 2009; 22:332-338.
44. Martinez Cantarin MP, Ertel A, Deloach S, et al. Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin Transl Sci 2010; 3:279-286.
45. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals genegender interactions in blood pressure in White Americans. Hypertension 2007; 49:96-106. (Pubitemid 46360347)
46. Staessen JA, Kuznetsova T, Zhang H, et al. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008; 51:1643-1650.
47. Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: an update. Curr Hypertens Rep 2008; 10:488-495.
48. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-676.
49. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41:677-687.
50. Adeyemo A, Gerry N, Chen G, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5:e1000564.
51. Wang Y, O'Connell JR, McArdle PF, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106:226-231.
52. Cho YS, Go MJ, Kim YJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009; 41:527-534.
53. + channels. Proc Natl Acad Sci USA 2004; 101:11886-11890. (Pubitemid 39095389)
54. Eckhart AD, Ozaki T, Tevaearai H, et al. Vascular-targeted overexpression ofG protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 2002; 61:749-758. (Pubitemid 34273154)
55. Gros R, Chorazyczewski J, Meek MD, et al.G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 2000; 35:38-42. (Pubitemid 30054234)
56. Cohn HI, Xi Y, Pesant S, et al.Gprotein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension 2009; 54:71-76.
57. Keys JR, Zhou RH, Harris DM, et al. Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation 2005; 112:1145-1153. (Pubitemid 41216121)